APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Colloids (Blood Plasma)

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

Selected research

Industry Growth & Trends

Global Colloids (Blood Plasma) Industry Growth and Trends Forecast to 2032

Report ID 17397964018 January 2026124 pages

Choose your research edition.

Industry ResearchColloids (Blood Plasma) Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Colloids (Blood Plasma) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Colloids (Blood Plasma) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Colloids (Blood Plasma) Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Colloids (Blood Plasma) Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.

Read the full market overview

The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.

Report Scope

This report provides a structured, data-driven view of the global Colloids (Blood Plasma) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Colloids (Blood Plasma) market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Colloids (Blood Plasma) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Colloids (Blood Plasma).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Colloids (Blood Plasma) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Colloids (Blood Plasma) Market by Company

CSL Behring

Baxter

Grifols

Octapharma

Kedrion

Shanghai Raas

CTBB

Hualan Bio

Rongsheng Pharmaceutical

Boya Rongsheng

B. Braun Medical

Fresenius Kabi

HOSPIRA

Axa parenterals

Fresenius Kabi (China)

CR Double-Crane

Kelun Group

Shandong Qidu Pharmaceutical

Shandong Hualu Pharmaceutical

Minsheng Pharma

Kanglepharm

Colloids (Blood Plasma) Segment by Type

Natural Type Colloids (Blood Plasma)

Synthetic Type Colloids (Blood Plasma)

Colloids (Blood Plasma) Segment by Application

Extensive Burns

Massive Blood or Plasma Loss

Hypovolemic Shock

Others

Colloids (Blood Plasma) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloids (Blood Plasma) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Colloids (Blood Plasma) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloids (Blood Plasma).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Colloids (Blood Plasma) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Natural Type Colloids (Blood Plasma) Table 2. Major Company of Synthetic Type Colloids (Blood Plasma) Table 3. Global Colloids (Blood Plasma) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 5. Global Colloids (Blood Plasma) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Colloids (Blood Plasma) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Colloids (Blood Plasma) Sales Market Share in Value by Type (2021-2026) Table 8. Global Colloids (Blood Plasma) Price by Type (2021-2026) & (USD/Kg) Table 9. Global Colloids (Blood Plasma) Sales by Type (2027-2032) & (MT) Table 10. Global Colloids (Blood Plasma) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Colloids (Blood Plasma) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Colloids (Blood Plasma) Sales Market Share in Value by Type (2027-2032) Table 13. Global Colloids (Blood Plasma) Price by Type (2027-2032) & (USD/Kg) Table 14. North America Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 15. North America Colloids (Blood Plasma) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 17. Europe Colloids (Blood Plasma) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 19. Asia-Pacific Colloids (Blood Plasma) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 21. Latin America Colloids (Blood Plasma) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 23. Middle East and Africa Colloids (Blood Plasma) Sales by Type (2021-2026) & (US$ Million) Table 24. Colloids (Blood Plasma) Industry Trends Table 25. Colloids (Blood Plasma) Industry Drivers Table 26. Colloids (Blood Plasma) Industry Opportunities and Challenges Table 27. Colloids (Blood Plasma) Industry Restraints Table 28. Global Colloids (Blood Plasma) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Colloids (Blood Plasma) Revenue Market Share by Company (2021-2026) Table 30. Global Colloids (Blood Plasma) Sales by Company (2021-2026) & (MT) Table 31. Global Colloids (Blood Plasma) Sales Share by Company (2021-2026) Table 32. Global Colloids (Blood Plasma) Market Price by Company (2021-2026) & (USD/Kg) Table 33. Global Colloids (Blood Plasma) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Colloids (Blood Plasma) Major Company Production Sites and Headquarters Table 35. Global Colloids (Blood Plasma) Company, Product Type & Application Table 36. Global Colloids (Blood Plasma) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Colloids (Blood Plasma) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Colloids (Blood Plasma) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Colloids (Blood Plasma) Sales by Region (2021-2026) & (MT) Table 41. Global Colloids (Blood Plasma) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Colloids (Blood Plasma) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Colloids (Blood Plasma) Sales Market Share in Value by Region (2021-2026) Table 44. Global Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Global Colloids (Blood Plasma) Sales by Region (2027-2032) & (MT) Table 46. Global Colloids (Blood Plasma) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Colloids (Blood Plasma) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Colloids (Blood Plasma) Sales Market Share in Value by Region (2027-2032) Table 49. Global Colloids (Blood Plasma) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 50. Global Colloids (Blood Plasma) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 52. Global Colloids (Blood Plasma) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Colloids (Blood Plasma) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Colloids (Blood Plasma) Sales Market Share in Value by Application (2021-2026) Table 55. Global Colloids (Blood Plasma) Price by Application (2021-2026) & (USD/Kg) Table 56. Global Colloids (Blood Plasma) Sales by Application (2027-2032) & (MT) Table 57. Global Colloids (Blood Plasma) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Colloids (Blood Plasma) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Colloids (Blood Plasma) Sales Market Share in Value by Application (2027-2032) Table 60. Global Colloids (Blood Plasma) Price by Application (2027-2032) & (USD/Kg) Table 61. North America Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 62. North America Colloids (Blood Plasma) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 64. Europe Colloids (Blood Plasma) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 66. Asia-Pacific Colloids (Blood Plasma) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 68. Latin America Colloids (Blood Plasma) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 70. Middle East and Africa Colloids (Blood Plasma) Sales by Application (2021-2026) & (US$ Million) Table 71. CSL Behring Company Information Table 72. CSL Behring Business Overview Table 73. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. CSL Behring Colloids (Blood Plasma) Product Portfolio Table 75. CSL Behring Recent Development Table 76. Baxter Company Information Table 77. Baxter Business Overview Table 78. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Baxter Colloids (Blood Plasma) Product Portfolio Table 80. Baxter Recent Development Table 81. Grifols Company Information Table 82. Grifols Business Overview Table 83. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Grifols Colloids (Blood Plasma) Product Portfolio Table 85. Grifols Recent Development Table 86. Octapharma Company Information Table 87. Octapharma Business Overview Table 88. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Octapharma Colloids (Blood Plasma) Product Portfolio Table 90. Octapharma Recent Development Table 91. Kedrion Company Information Table 92. Kedrion Business Overview Table 93. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 94. Kedrion Colloids (Blood Plasma) Product Portfolio Table 95. Kedrion Recent Development Table 96. Shanghai Raas Company Information Table 97. Shanghai Raas Business Overview Table 98. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 99. Shanghai Raas Colloids (Blood Plasma) Product Portfolio Table 100. Shanghai Raas Recent Development Table 101. CTBB Company Information Table 102. CTBB Business Overview Table 103. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 104. CTBB Colloids (Blood Plasma) Product Portfolio Table 105. CTBB Recent Development Table 106. Hualan Bio Company Information Table 107. Hualan Bio Business Overview Table 108. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 109. Hualan Bio Colloids (Blood Plasma) Product Portfolio Table 110. Hualan Bio Recent Development Table 111. Rongsheng Pharmaceutical Company Information Table 112. Rongsheng Pharmaceutical Business Overview Table 113. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 114. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 115. Rongsheng Pharmaceutical Recent Development Table 116. Boya Rongsheng Company Information Table 117. Boya Rongsheng Business Overview Table 118. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 119. Boya Rongsheng Colloids (Blood Plasma) Product Portfolio Table 120. Boya Rongsheng Recent Development Table 121. B. Braun Medical Company Information Table 122. B. Braun Medical Business Overview Table 123. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 124. B. Braun Medical Colloids (Blood Plasma) Product Portfolio Table 125. B. Braun Medical Recent Development Table 126. Fresenius Kabi Company Information Table 127. Fresenius Kabi Business Overview Table 128. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 129. Fresenius Kabi Colloids (Blood Plasma) Product Portfolio Table 130. Fresenius Kabi Recent Development Table 131. HOSPIRA Company Information Table 132. HOSPIRA Business Overview Table 133. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 134. HOSPIRA Colloids (Blood Plasma) Product Portfolio Table 135. HOSPIRA Recent Development Table 136. Axa parenterals Company Information Table 137. Axa parenterals Business Overview Table 138. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 139. Axa parenterals Colloids (Blood Plasma) Product Portfolio Table 140. Axa parenterals Recent Development Table 141. Fresenius Kabi (China) Company Information Table 142. Fresenius Kabi (China) Business Overview Table 143. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 144. Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio Table 145. Fresenius Kabi (China) Recent Development Table 146. CR Double-Crane Company Information Table 147. CR Double-Crane Business Overview Table 148. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 149. CR Double-Crane Colloids (Blood Plasma) Product Portfolio Table 150. CR Double-Crane Recent Development Table 151. Kelun Group Company Information Table 152. Kelun Group Business Overview Table 153. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 154. Kelun Group Colloids (Blood Plasma) Product Portfolio Table 155. Kelun Group Recent Development Table 156. Shandong Qidu Pharmaceutical Company Information Table 157. Shandong Qidu Pharmaceutical Business Overview Table 158. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 159. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 160. Shandong Qidu Pharmaceutical Recent Development Table 161. Shandong Hualu Pharmaceutical Company Information Table 162. Shandong Hualu Pharmaceutical Business Overview Table 163. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 164. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 165. Shandong Hualu Pharmaceutical Recent Development Table 166. Minsheng Pharma Company Information Table 167. Minsheng Pharma Business Overview Table 168. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 169. Minsheng Pharma Colloids (Blood Plasma) Product Portfolio Table 170. Minsheng Pharma Recent Development Table 171. Kanglepharm Company Information Table 172. Kanglepharm Business Overview Table 173. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 174. Kanglepharm Colloids (Blood Plasma) Product Portfolio Table 175. Kanglepharm Recent Development Table 176. North America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 177. North America Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 178. North America Colloids (Blood Plasma) Sales Market Share by Country (2021-2026) Table 179. North America Colloids (Blood Plasma) Sales Forecast by Country (2027-2032) & (MT) Table 180. North America Colloids (Blood Plasma) Sales Market Share Forecast by Country (2027-2032) Table 181. North America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. North America Colloids (Blood Plasma) Market Size by Country (2021-2026) & (US$ Million) Table 183. North America Colloids (Blood Plasma) Market Share by Country (2021-2026) Table 184. North America Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. North America Colloids (Blood Plasma) Market Share Forecast by Country (2027-2032) Table 186. Europe Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 187. Europe Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 188. Europe Colloids (Blood Plasma) Sales Market Share by Country (2021-2026) Table 189. Europe Colloids (Blood Plasma) Sales Forecast by Country (2027-2032) & (MT) Table 190. Europe Colloids (Blood Plasma) Sales Market Share Forecast by Country (2027-2032) Table 191. Europe Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Europe Colloids (Blood Plasma) Market Size by Country (2021-2026) & (US$ Million) Table 193. Europe Colloids (Blood Plasma) Market Share by Country (2021-2026) Table 194. Europe Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Europe Colloids (Blood Plasma) Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 198. Asia-Pacific Colloids (Blood Plasma) Sales Market Share by Country (2021-2026) Table 199. Asia-Pacific Colloids (Blood Plasma) Sales Forecast by Country (2027-2032) & (MT) Table 200. Asia-Pacific Colloids (Blood Plasma) Sales Market Share Forecast by Country (2027-2032) Table 201. Asia-Pacific Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Asia-Pacific Colloids (Blood Plasma) Market Size by Country (2021-2026) & (US$ Million) Table 203. Asia-Pacific Colloids (Blood Plasma) Market Share by Country (2021-2026) Table 204. Asia-Pacific Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Asia-Pacific Colloids (Blood Plasma) Market Share Forecast by Country (2027-2032) Table 206. Latin America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 207. Latin America Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 208. Latin America Colloids (Blood Plasma) Sales Market Share by Country (2021-2026) Table 209. Latin America Colloids (Blood Plasma) Sales Forecast by Country (2027-2032) & (MT) Table 210. Latin America Colloids (Blood Plasma) Sales Market Share Forecast by Country (2027-2032) Table 211. Latin America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Latin America Colloids (Blood Plasma) Market Size by Country (2021-2026) & (US$ Million) Table 213. Latin America Colloids (Blood Plasma) Market Share by Country (2021-2026) Table 214. Latin America Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Latin America Colloids (Blood Plasma) Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 218. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country (2021-2026) Table 219. Middle East and Africa Colloids (Blood Plasma) Sales Forecast by Country (2027-2032) & (MT) Table 220. Middle East and Africa Colloids (Blood Plasma) Sales Market Share Forecast by Country (2027-2032) Table 221. Middle East and Africa Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Middle East and Africa Colloids (Blood Plasma) Market Size by Country (2021-2026) & (US$ Million) Table 223. Middle East and Africa Colloids (Blood Plasma) Market Share by Country (2021-2026) Table 224. Middle East and Africa Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Middle East and Africa Colloids (Blood Plasma) Market Share Forecast by Country (2027-2032) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Colloids (Blood Plasma) Distributors List Table 229. Colloids (Blood Plasma) Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Colloids (Blood Plasma) Image Figure 2. Global Colloids (Blood Plasma) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Colloids (Blood Plasma) Market Size (2021-2032) & (US$ Million) Figure 4. Global Colloids (Blood Plasma) Sales (2021-2032) & (MT) Figure 5. Natural Type Colloids (Blood Plasma) Image Figure 6. Global Natural Type Colloids (Blood Plasma) Sales YoY Growth (2021-2032) & (MT) Figure 7. Synthetic Type Colloids (Blood Plasma) Image Figure 8. Global Synthetic Type Colloids (Blood Plasma) Sales YoY Growth (2021-2032) & (MT) Figure 9. Global Colloids (Blood Plasma) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Colloids (Blood Plasma) Market Share by Type 2025 VS 2032 Figure 11. North America Colloids (Blood Plasma) Sales Market Share in Volume by Type in 2025 Figure 12. North America Colloids (Blood Plasma) Sales Market Share in Value by Type in 2025 Figure 13. Europe Colloids (Blood Plasma) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Colloids (Blood Plasma) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Colloids (Blood Plasma) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Colloids (Blood Plasma) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Colloids (Blood Plasma) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Colloids (Blood Plasma) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Colloids (Blood Plasma) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Colloids (Blood Plasma) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Colloids (Blood Plasma) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Extensive Burns Image Figure 24. Global Extensive Burns Sales YoY Growth (2021-2032) & (MT) Figure 25. Massive Blood or Plasma Loss Image Figure 26. Global Massive Blood or Plasma Loss Sales YoY Growth (2021-2032) & (MT) Figure 27. Hypovolemic Shock Image Figure 28. Global Hypovolemic Shock Sales YoY Growth (2021-2032) & (MT) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (MT) Figure 31. Global Colloids (Blood Plasma) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Colloids (Blood Plasma) Market Share by Application 2025 VS 2032 Figure 33. North America Colloids (Blood Plasma) Sales Market Share in Volume by Application in 2025 Figure 34. North America Colloids (Blood Plasma) Sales Market Share in Value by Application in 2025 Figure 35. Europe Colloids (Blood Plasma) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Colloids (Blood Plasma) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Colloids (Blood Plasma) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Colloids (Blood Plasma) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Colloids (Blood Plasma) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Colloids (Blood Plasma) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Colloids (Blood Plasma) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Colloids (Blood Plasma) Sales Market Share in Value by Application in 2025 Figure 43. North America Colloids (Blood Plasma) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 44. North America Colloids (Blood Plasma) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Colloids (Blood Plasma) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Colloids (Blood Plasma) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 48. Europe Colloids (Blood Plasma) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Colloids (Blood Plasma) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Colloids (Blood Plasma) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 52. Asia-Pacific Colloids (Blood Plasma) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Colloids (Blood Plasma) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Colloids (Blood Plasma) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 56. Latin America Colloids (Blood Plasma) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Colloids (Blood Plasma) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Colloids (Blood Plasma) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 60. Middle East and Africa Colloids (Blood Plasma) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Colloids (Blood Plasma) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Colloids (Blood Plasma) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Colloids (Blood Plasma) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Type Colloids (Blood Plasma)
  • Synthetic Type Colloids (Blood Plasma)
Applications
  • Extensive Burns
  • Massive Blood or Plasma Loss
  • Hypovolemic Shock
  • Others
Companies covered
  • CSL Behring
  • Baxter
  • Grifols
  • Octapharma
  • Kedrion
  • Shanghai Raas
  • CTBB
  • Hualan Bio
  • Rongsheng Pharmaceutical
  • Boya Rongsheng
  • B. Braun Medical
  • Fresenius Kabi
  • HOSPIRA
  • Axa parenterals
  • Fresenius Kabi (China)
  • CR Double-Crane
  • Kelun Group
  • Shandong Qidu Pharmaceutical
  • Shandong Hualu Pharmaceutical
  • Minsheng Pharma
  • Kanglepharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Colloids (Blood Plasma) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Colloids (Blood Plasma) Market by Type
  6. 1.3.1 Natural Type Colloids (Blood Plasma)
  7. 1.3.2 Synthetic Type Colloids (Blood Plasma)
  8. 1.4 Global Colloids (Blood Plasma) Market Size by Type
  9. 1.4.1 Global Colloids (Blood Plasma) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Colloids (Blood Plasma) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Colloids (Blood Plasma) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Colloids (Blood Plasma) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Colloids (Blood Plasma) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Colloids (Blood Plasma) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Colloids (Blood Plasma) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Colloids (Blood Plasma) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Colloids (Blood Plasma) Industry Trends
  2. 2.2 Colloids (Blood Plasma) Industry Drivers
  3. 2.3 Colloids (Blood Plasma) Industry Opportunities and Challenges
  4. 2.4 Colloids (Blood Plasma) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Colloids (Blood Plasma) Revenue (2021-2026)
  2. 3.2 Global Top Players by Colloids (Blood Plasma) Sales (2021-2026)
  3. 3.3 Global Top Players by Colloids (Blood Plasma) Price (2021-2026)
  4. 3.4 Global Colloids (Blood Plasma) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Colloids (Blood Plasma) Major Company Production Sites & Headquarters
  6. 3.6 Global Colloids (Blood Plasma) Company, Product Type & Application
  7. 3.7 Global Colloids (Blood Plasma) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Colloids (Blood Plasma) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Colloids (Blood Plasma) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Colloids (Blood Plasma) Tier 1, Tier 2, and Tier 3
4 Colloids (Blood Plasma) Regional Status and Outlook
  1. 4.1 Global Colloids (Blood Plasma) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Colloids (Blood Plasma) Historic Market Size by Region
  3. 4.2.1 Global Colloids (Blood Plasma) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Colloids (Blood Plasma) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Colloids (Blood Plasma) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Colloids (Blood Plasma) Forecasted Market Size by Region
  7. 4.3.1 Global Colloids (Blood Plasma) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Colloids (Blood Plasma) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Colloids (Blood Plasma) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Colloids (Blood Plasma) by Application
  1. 5.1 Colloids (Blood Plasma) Market by Application
  2. 5.1.1 Extensive Burns
  3. 5.1.2 Massive Blood or Plasma Loss
  4. 5.1.3 Hypovolemic Shock
  5. 5.1.4 Others
  6. 5.2 Global Colloids (Blood Plasma) Market Size by Application
  7. 5.2.1 Global Colloids (Blood Plasma) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Colloids (Blood Plasma) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Colloids (Blood Plasma) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Colloids (Blood Plasma) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Colloids (Blood Plasma) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Colloids (Blood Plasma) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Colloids (Blood Plasma) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Colloids (Blood Plasma) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL Behring
  2. 6.1.1 CSL Behring Company Information
  3. 6.1.2 CSL Behring Business Overview
  4. 6.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
  6. 6.1.5 CSL Behring Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 Grifols
  14. 6.3.1 Grifols Company Information
  15. 6.3.2 Grifols Business Overview
  16. 6.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
  18. 6.3.5 Grifols Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 Kedrion
  26. 6.5.1 Kedrion Company Information
  27. 6.5.2 Kedrion Business Overview
  28. 6.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
  30. 6.5.5 Kedrion Recent Developments
  31. 6.6 Shanghai Raas
  32. 6.6.1 Shanghai Raas Company Information
  33. 6.6.2 Shanghai Raas Business Overview
  34. 6.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
  36. 6.6.5 Shanghai Raas Recent Developments
  37. 6.7 CTBB
  38. 6.7.1 CTBB Company Information
  39. 6.7.2 CTBB Business Overview
  40. 6.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
  42. 6.7.5 CTBB Recent Developments
  43. 6.8 Hualan Bio
  44. 6.8.1 Hualan Bio Company Information
  45. 6.8.2 Hualan Bio Business Overview
  46. 6.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
  48. 6.8.5 Hualan Bio Recent Developments
  49. 6.9 Rongsheng Pharmaceutical
  50. 6.9.1 Rongsheng Pharmaceutical Company Information
  51. 6.9.2 Rongsheng Pharmaceutical Business Overview
  52. 6.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  54. 6.9.5 Rongsheng Pharmaceutical Recent Developments
  55. 6.10 Boya Rongsheng
  56. 6.10.1 Boya Rongsheng Company Information
  57. 6.10.2 Boya Rongsheng Business Overview
  58. 6.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
  60. 6.10.5 Boya Rongsheng Recent Developments
  61. 6.11 B. Braun Medical
  62. 6.11.1 B. Braun Medical Company Information
  63. 6.11.2 B. Braun Medical Business Overview
  64. 6.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
  66. 6.11.5 B. Braun Medical Recent Developments
  67. 6.12 Fresenius Kabi
  68. 6.12.1 Fresenius Kabi Company Information
  69. 6.12.2 Fresenius Kabi Business Overview
  70. 6.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
  72. 6.12.5 Fresenius Kabi Recent Developments
  73. 6.13 HOSPIRA
  74. 6.13.1 HOSPIRA Company Information
  75. 6.13.2 HOSPIRA Business Overview
  76. 6.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
  78. 6.13.5 HOSPIRA Recent Developments
  79. 6.14 Axa parenterals
  80. 6.14.1 Axa parenterals Company Information
  81. 6.14.2 Axa parenterals Business Overview
  82. 6.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
  84. 6.14.5 Axa parenterals Recent Developments
  85. 6.15 Fresenius Kabi (China)
  86. 6.15.1 Fresenius Kabi (China) Company Information
  87. 6.15.2 Fresenius Kabi (China) Business Overview
  88. 6.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
  90. 6.15.5 Fresenius Kabi (China) Recent Developments
  91. 6.16 CR Double-Crane
  92. 6.16.1 CR Double-Crane Company Information
  93. 6.16.2 CR Double-Crane Business Overview
  94. 6.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
  96. 6.16.5 CR Double-Crane Recent Developments
  97. 6.17 Kelun Group
  98. 6.17.1 Kelun Group Company Information
  99. 6.17.2 Kelun Group Business Overview
  100. 6.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
  102. 6.17.5 Kelun Group Recent Developments
  103. 6.18 Shandong Qidu Pharmaceutical
  104. 6.18.1 Shandong Qidu Pharmaceutical Company Information
  105. 6.18.2 Shandong Qidu Pharmaceutical Business Overview
  106. 6.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  108. 6.18.5 Shandong Qidu Pharmaceutical Recent Developments
  109. 6.19 Shandong Hualu Pharmaceutical
  110. 6.19.1 Shandong Hualu Pharmaceutical Company Information
  111. 6.19.2 Shandong Hualu Pharmaceutical Business Overview
  112. 6.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  114. 6.19.5 Shandong Hualu Pharmaceutical Recent Developments
  115. 6.20 Minsheng Pharma
  116. 6.20.1 Minsheng Pharma Company Information
  117. 6.20.2 Minsheng Pharma Business Overview
  118. 6.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
  120. 6.20.5 Minsheng Pharma Recent Developments
  121. 6.21 Kanglepharm
  122. 6.21.1 Kanglepharm Company Information
  123. 6.21.2 Kanglepharm Business Overview
  124. 6.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
  126. 6.21.5 Kanglepharm Recent Developments
7 North America by Country
  1. 7.1 North America Colloids (Blood Plasma) Sales by Country
  2. 7.1.1 North America Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Colloids (Blood Plasma) Sales by Country (2021-2026)
  4. 7.1.3 North America Colloids (Blood Plasma) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Colloids (Blood Plasma) Market Size by Country
  6. 7.2.1 North America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Colloids (Blood Plasma) Market Size by Country (2021-2026)
  8. 7.2.3 North America Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Colloids (Blood Plasma) Sales by Country
  2. 8.1.1 Europe Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Colloids (Blood Plasma) Sales by Country (2021-2026)
  4. 8.1.3 Europe Colloids (Blood Plasma) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Colloids (Blood Plasma) Market Size by Country
  6. 8.2.1 Europe Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Colloids (Blood Plasma) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Colloids (Blood Plasma) Sales by Country
  2. 9.1.1 Asia-Pacific Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Colloids (Blood Plasma) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Colloids (Blood Plasma) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Colloids (Blood Plasma) Market Size by Country
  6. 9.2.1 Asia-Pacific Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Colloids (Blood Plasma) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Colloids (Blood Plasma) Sales by Country
  2. 10.1.1 South America Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Colloids (Blood Plasma) Sales by Country (2021-2026)
  4. 10.1.3 South America Colloids (Blood Plasma) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Colloids (Blood Plasma) Market Size by Country
  6. 10.2.1 South America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Colloids (Blood Plasma) Market Size by Country (2021-2026)
  8. 10.2.3 South America Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Colloids (Blood Plasma) Sales by Country
  2. 11.1.1 Middle East and Africa Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Colloids (Blood Plasma) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Colloids (Blood Plasma) Market Size by Country
  6. 11.2.1 Middle East and Africa Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Colloids (Blood Plasma) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Colloids (Blood Plasma) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Colloids (Blood Plasma) Value Chain Analysis
  2. 12.1.1 Colloids (Blood Plasma) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Colloids (Blood Plasma) Production Mode & Process
  7. 12.2 Colloids (Blood Plasma) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Colloids (Blood Plasma) Distributors
  10. 12.2.3 Colloids (Blood Plasma) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst